References
- Bergkivisk L, Adami H, Persson J, Hoove R, Schairer C. The risk of breast cancer after estrogen and estrogen-progestin replacement. New Engl J Med. 1989; 321: 293–7
- Jacgues E, Rossouw MBChB, Garnet L, Anderson Ross L, Prentice, , et al.; for Writing Group for the Women's Health Initiative Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women – principle results from women's health initiative randomized controlled trial. JAMA. 2002;288(3):321–33.
- Nachtigall LE, Baber RJ, Barentsen R, Durand N, Panay N, Pitkin J, et al. Complementary and hormonal therapy for vasomotor symptom relief: a conservative clinical approach. J Obstet Gynaecol Can. 2006; 28(4)279–89
- Rohdewald P. Pycnogenol®, French Maritime Pine Bark Extract. Encyclopedia of dietary supplements. New York: Marcel Dekker; 2005. pp 545–53.
- Magyar Z, Fel T. Treatment of menopausal symptoms – review of the current literature. Orv Hetil. 2006; 147(19)879–85
- Downey LA, Ryan JQ, Croft KD, Stough C. The effects of the antioxidant pycnogenol on cognitive performance, serum lipids, endocrinological and oxidative stress biomarkers in an elderly population. J Psychopharmacol. (accepted).
- Kohama T. Clinical applications of Pycnogenol® in Japan. Prog Med. 2004; 24: 1503–10
- Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956; 11(3)298–300
- Hunter M. The Women's Health Questionnaire: a measure of physical and emotional well-being of mid-aged women. Psychol Health. 1992; 7(1)45–54
- Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci. 1993; 84: 407–12
- Durackova Z, Trebaticky B, Novotny V, Zitnanova A, Breza J. Lipid metabolism and erectile function improvement by Pycnogenol®, extract from the bark of Pinus pinaster in patients suffering from erectile dysfunction – a pilot study. Nutr Res. 2003; 23: 1189–98
- Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol. 1998; 51(11)1025–36
- Wiklund I, Karlberg J, Lindgren R, Sandin K, Mattsson LA. A Swedish version of the Women's Health Questionnaire. A measure of postmenopausal complaints. Acta Obstet Gynecol Scand. 1993; 72(8)648–55
- Kohama T. Pycnogenol® alleviates pain associated with pregnancy. Phytother Res. 2006; 20: 232–4
- De la Torre JC, Aliev G. Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: spatial memory and immunocytochemical changes. J Cereb Blood Flow Metab. 2005; 25(6)663–72
- Plech A, Klimkiewicz T, Maksym B. Effect of l-arginine on memory in rats. Pol J Pharmacol. 2003; 55(6)987–92
- Yamada K, Noda Y, Nakayama S, Komori Y, Sugihara H, Hasegawa T, et al. Role of nitric oxide in learning and memory and in monoamine metabolism in the rat brain. Br J Pharmacol. 1995; 115: 852–8
- Schmidt HW, Walter U. NO at work. Cell. 1994; 78: 919–25
- Trebaticka J, Kopasova S, Hradecna Z, Cinovsky K, Skodacek I, Suba J, et al. Treatment of ADHD with French maritime pine bark extract, Pycnogenol. Eur Child Adolesc Psychiatry. 2006; 15(6)329–35